Mechanistically, [212Pb]VMT01 induced immunogenic cell death, sensitizing melanoma cells to ICI therapy and promoting the infiltration of CD3+, CD4+, and CD8+ T lymphocytes within the tumor microenvironment [210]. Here, CD8A is linked to melanoma.